These distinctive properties position ZW25 as a promising option in the treatment of gastrointestinal cancers, particularly in HER2-positive GEJ adenocarcinomas and HER2-positive biliary tract cancers (BTC). The gene discussed is ERBB2; the disease is biliary tract cancer.